Biotech Company GangaGen raises $1.8mn

Bangalore (and US) based Biotech research company, GangaGen has raised $1.8mn from ATEL ventures.

The funding will be used to develop treatments for antibiotic-resistant bacterial infections like MRSA, a skin infection that plagues hospitals, and pneumonia (via)

Recommended Read: Green Tech Investments in India | The Great Indian Energy Innovation!

Add comment

NextBigWhat brings you curated insights and wisdom on product and growth from the wild web.

Over 2 million people receive our weekly curated insights.